Evidence map›Paper›PMID 25210499›Full record

ArticleInternational journal of biological sciences2014

The prostate basal cell (BC) heterogeneity and the p63-positive BC differentiation spectrum in mice.

Dong-Kee Lee, Yonghong Liu, Lan Liao, Fen Wang, Jianming Xu

Open access · goldAbstract read
In one paragraph

Article in International journal of biological sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 60 citations in OpenAlex.

  1. The role of estrogen receptor β in maintaining basal cells and modulating the immune environment in the prostate.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Prostate Cancer Stem Cells: Biology and Treatment Implications.International journal of molecular sciences · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Contribution ofeLife · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Dong-Kee Lee1. Department of Molecular and Cellular Biology, Houston, Texas, USA;
Yonghong Liu1. Department of Molecular and Cellular Biology, Houston, Texas, USA; ; 2. Institute of Bioscience and Technology, Texas A&M University Health Science Center, Houston, TX, USA;
Lan Liao1. Department of Molecular and Cellular Biology, Houston, Texas, USA;
Fen Wang2. Institute of Bioscience and Technology, Texas A&M University Health Science Center, Houston, TX, USA;
Jianming Xu1. Department of Molecular and Cellular Biology, Houston, Texas, USA; ; 3. Institute for Cancer Medicine, Luzhou Medical College, Luzhou, Sichuan, China.
Cellular Research (United States) · USTexas A&M Health Science Center · USThe University of Texas Health Science Center at Houston · US

Funding

TISSUE COACTIVATOR AND RECEPTOR EXPRESSION FINGERPRINTSP01DK059820 · NIDDK · INSTITUT DE GENETIQUE ET BIOLOGIE MOLECU · PI O'MALLEY, BERT W · 2001 to 2016
$23.1M
The Role of SRC-1 in Breast CancerR01CA112403 · NCI · BAYLOR COLLEGE OF MEDICINE · PI XU, JIANMING · 2006 to 2016
$2.9M
Roles of SRC-3 in Development and DiseaseR01DK058242 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI XU, JIANMING · 2000 to 2013
$2.8M
NCI NIH HHS CA112403NCI NIH HHS R01 CA112403NIDDK NIH HHS DK058242NIDDK NIH HHS DK059820NIDDK NIH HHS P01 DK059820NIDDK NIH HHS R01 DK058242
6 · The paper itself

Abstract

The prostate epithelium is composed of basal (BC), luminal (LEC), and neuroendocrine (NEC) cells. It is unclear how many subtypes of BCs in the prostate and which subtype of BCs contains the main stem cell niche in the adult prostate. Here we report seven BC subpopulations according to their p63, cytokeratin 14 (K14) and K5 expression patterns, including p63-positive/K14-negative/K5-negative (p63+/K14-/K5-), p63-/K14+/K5-, p63-/K14-/K5+, p63+/K14+/K5-, p63+/K14-/K5+, p63-/K14+/K5+, and p63+/K14+/K5+ BCs. We generated a p63-CreERT2 knock-in mouse line that expresses tamoxifen-inducible Cre activity in the p63-expressing cells, including the prostate BCs. We then crossbred this line with ROSA26R mice, and generated p63-CreERT2×ROSA26R bi-genic mice harboring the Cre-activated β-galactosidase reporter gene. We treated these bi-genic mice with tamoxifen to mark the p63+ BCs at different ages or under different hormonal conditions, and then traced the lineage differentiation of these genetically labeled BCs. We discovered that these p63+ BCs contain self-renewable stem cells in culture and efficiently differentiated into LECs, NECs and BCs in the postnatal, adult and re-generating mouse prostates. Therefore, BC population contains heterogeneous BCs that express different combinations of the p63, K14 and K5 differentiation markers. Because K14+ and K5+ BCs were previously shown to be extremely inefficient to produce LECs in adulthood, we propose that the p63+/K5-/K14- subpopulation of BCs contains most stem-like cells, especially in adult animals.

Indexed as

AndrogensAnimalsCell DifferentiationEpithelial CellsEpitheliumEstrogen AntagonistsGene Expression Regulation, NeoplasticHomeostasisMaleMiceMultipotent Stem CellsPhosphoproteinsProstatic NeoplasmsTamoxifenTrans-ActivatorsAndrogensEstrogen AntagonistsPhosphoproteinsTamoxifenTrans-ActivatorsTrp63 protein, mousebasal cell differentiationlineage tracingp63Prostate epitheliumstem cell.

Identifiers

PMID25210499
PMCPMC4159692
OpenAlexW2154002218

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.